ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Vaxxilon receives grant to develop new prophylactic vaccine pharmaceutical-technology
August 21, 2019Switzerland-based synthetic vaccines firm Vaxxilon has received a funding grant from CARB-X to support the development of a prophylactic, multivalent vaccine against carbapenem-resistant Klebsiella pneumoniae (crKP).
Pharma Sources Insight January 2025
